Position
Renaissance Technologies in Co-Diagnostics, Inc.
Back to the book · All holders of CODX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $36.6K$0.17 → $3.10
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 730.3K | $123.1K | — | — | — | 0.0% |
| Q2 2026 | 12.5K | $38.8K | $3.10 | $36.6K | −$121K | 0.0% |